IP Verse

Treatment Or Prevention Of Cardiovascular Events Via The Administration Of A Colchicine Derivative

Patent No. EP2914255 (titled "Treatment Or Prevention Of Cardiovascular Events Via The Administration Of A Colchicine Derivative") was filed by Murray & Poole Enterprises on Nov 1, 2013. The application was issued on Jul 21, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSApr 21, 2022D YOUNG
PHARMASCIENCEApr 20, 2022MAIWALD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2914255

MURRAY & POOLE ENTERPRISES
Application Number
EP13851803A
Filing Date
Nov 1, 2013
Status
Granted And Under Opposition
Jun 18, 2021
Publication Date
Jul 21, 2021
External Links
Slate, Register , Google Patents